2-(1-((2-(2-ethyl-1H-benzo[d]imidazol-1-yl)-9-methyl-6-morpholino-9H-purin-8-yl)methyl)piperidin-4-yl)-2-methylpropan-1-ol 分子结构式
HCID59605673

2-(1-((2-(2-ethyl-1H-benzo[d]imidazol-1-yl)-9-methyl-6-morpholino-9H-purin-8-yl)methyl)piperidin-4-yl)-2-methylpropan-1-ol

2-[1-[[2-(2-ethylbenzimidazol-1-yl)-9-methyl-6-morpholin-4-ylpurin-8-yl]methyl]piperidin-4-yl]-2-methylpropan-1-ol

C29H40N8O2532.7 g/mol

IDENTITY

结构与身份

标准SMILES
CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)CO)CC3)n(C)c2n1
InChIKey
CBIMUBSOAJKANU-UHFFFAOYSA-N
分子式
C29H40N8O2
平均分子量
532.7 g/mol
单同位素质量
532.32742255

COMPUTED

结构计算性质

已同步
XLogP
3.6
极性表面积
97.4 Ų
氢键供体
1
氢键受体
8
可旋转键
7
重原子
39
形式电荷
0
复杂度
804

ALIASES

名称与别名

共 3 条
SCHEMBL2676133CBIMUBSOAJKANU-UHFFFAOYSA-N2-(1-((2-(2-ethyl-1H-benzo[d]imidazol-1-yl)-9-methyl-6-morpholino-9H-purin-8-yl)methyl)piperidin-4-yl)-2-methylpropan-1-ol

REACTIONS

参与反应

3
HRID 1209722 反应方程式

Training data from https://doi.org/10.1039/C8SC04228D (5/10) · 10.1039/C8SC04228D

查看
HRID 1923081 反应方程式

uspto-grants-2012_05 · 10.6084/m9.figshare.5104873.v1 · US08173650B2

查看
HRID 1945900 反应方程式

uspto-grants-2013_03 · 10.6084/m9.figshare.5104873.v1 · US08394796B2

查看